In this video, Arvind N. Dasari, MD, MS, discussed the results of the CheckMate 8HW trial in which nivolumab and ipilimumab were compared with nivolumab monotherapy for microsatellite instability-high ...
IMCR's strong balance sheet, with over $800 million in liquid assets, positions them well for future R&D or even a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback